The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

A wireless retinal implant called PRIMA is changing that reality by helping blind patients read and recognize faces again.

EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics ...

ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...

Dr Sethi shares the various health benefits of eggs and how it supports your wellbeing, from better energy to improved blood ...